menu Search
Search Drug Information, Images & Medical News

Search Drug Information, Images & Medical News | MIMS Hongkong

Advanced Search

 

MORE
One in five patients with chronic HBV infection achieves functional cure with bepirovirsen 10 Jun 2026
The novel antisense oligonucleotide bepirovirsen has induced functional cure in one-fifth of patients with chronic hepatitis B virus (HBV) infection in the phase 3 B-Well 1 and B-Well 2 trials.
Rheumatology patients must undergo screening for anxiety, depression, FM: study
10 Jun 2026
Heavy alcohol consumption raises CRC risk
10 Jun 2026
TNFi, IL-17i reduce risk of osteoporosis, but not hip fracture, in r-axSpA patients
10 Jun 2026
LNF-based regimens may alter trajectory of CHD treatment
10 Jun 2026
Lutikizumab shows promise in refractory hidradenitis suppurativa
09 Jun 2026
Adverse reproductive factors plus unhealthy lifestyle tied to higher risk of cognitive decline
09 Jun 2026
Tezepelumab cuts oral corticosteroid use without compromising asthma control
09 Jun 2026
Early CKD screening in CAD patients must include eGFR, UACR: study
09 Jun 2026
Rapid response to obesity medications tied to greater weight loss
09 Jun 2026
Healthy low-carb, low-fat diets may lower CHD risk
09 Jun 2026
MORE
Lowering LDL-C with bempedoic acid in patients with complex clinical profiles: European experience and local cases 02 Jun 2026;
LDL-cholesterol (LDL-C) is the main driver of atherosclerotic cardiovascular disease (ASCVD), yet LDL-C control in high-risk patients remains far from optimal. At an industry-sponsored meeting, Professor Vivencio Barrios from Ramón y Cajal University Hospital, Spain, discussed the role of bempedoic acid in managing complex patients, while Dr Walter Wai-Chee Chen, Specialist in Cardiology in private practice in Hong Kong, shared local cases of bempedoic acid use in patients with mild-to-moderate chronic kidney disease (CKD) and complex clinical profiles.
Achieving repigmentation with ruxolitinib cream in Chinese vitiligo patients
Dr. Chi-Keung Yeung, Specialist in Dermatology and Venereology, Hong Kong, 19 May 2026
Increasing confidence in starting aflibercept 8 mg for nAMD — two HK cases
Dr. Raymond Wong, Specialist in Ophthalmology, Private practice, Hong Kong, 14 May 2026
Nerandomilast offers potential benefits beyond reduction in FVC decline for patients with IPF and PPF
Prof. Philip Molyneaux, Imperial College, London, UK, 13 May 2026
SHOW ALL

New Molecule

2 New

New Indication

3 New

New Brand

10 New

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
ADVANCED SEARCH
Markings
Shape
Form
Color 1
Color 2
Advertisement
MORE
From Registry Evidence to Innovation: New Horizons in LDL-C Management
Doctors CME Unit: 0.5/1 point
Latest updates and safety optimisation in EGFR-mutant NSCLC
Doctors CME Unit: 1 point
Updates on the Classification, Diagnosis, and Treatment of Urinary Tract Infections (UTIs) in Adults
Doctors CME Unit: 0.5/1 point
Advertisement
Advertisement

MIMS is a trusted, accurate and user-friendly medication information platform. Designed to empower both healthcare professionals and general public to support informed healthcare decisions, our leading drug directory provides clear, reliable information on prescription drugs, over-the-counter medications and other medical resources.

Learn More About Us

Frequently Asked Questions

Absolutely. Our database is continuously updated by medical editors and references authoritative sources, ensuring accuracy and credibility.

Yes. You can access MIMS.com on desktop or mobile, and we also offer an app for on-the-go use.

Use the search bar located at the top of the homepage and enter either the brand name or generic name of the drug.

Go to "Diseases" and use the search bar located at the top of the page and enter the name of the disease.

Go to "Medical News & Updates" to access latest news and medical updates in MIMS.com
Explore More FAQs